Searches , social queries for TOCILIZUMAB
Search references for TOCILIZUMAB. Phrases containing TOCILIZUMAB
See searches and references containing TOCILIZUMAB!
Search references for TOCILIZUMAB. Phrases containing TOCILIZUMAB
See searches and references containing TOCILIZUMAB!TOCILIZUMAB
Immunosuppressive drug
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile
Tocilizumab
Inflammatory disease of large blood vessels
small amount of aspirin is beneficial. Injections of tocilizumab may also be used. Tocilizumab is a humanized antibody that targets the interleukin-6
Giant_cell_arteritis
Drugs to suppress IL-6 signalling
unresponsive to TNF inhibitors. The first approved medication in this class, tocilizumab (Actemra), is an antibody directed against the IL6-receptor. The second
Anti-interleukin-6
Test of existing medicines on COVID-19
dexamethasone (a steroid, which reduces inflammation) Intravenous immunoglobulin Tocilizumab (an anti-inflammatory) Anakinra (an anti-inflammatory) The following
RECOVERY_Trial
Accumulation of excess fluid in tissue
pregabalin, NSAIDs, steroids, anti-interleukin-6 inhibitors (e.g., tocilizumab). Chronic leg vein insufficiency (duplex ultrasound of leg veins – often
Edema
Cytokine protein
human adults can be reversed by the IL-6 receptor blocking antibody tocilizumab. Together with the findings that IL-6 prevents obesity, stimulates lipolysis
Interleukin_6
Category of drugs
cyclophosphamide therapy has failed. Furthermore, should DMARDs fail, tocilizumab can be used for tumor necrosis factor (TNF) inhibitor treatments in NICE
Disease-modifying antirheumatic drug
Disease-modifying_antirheumatic_drug
Medical condition
also be used. There is tentative evidence for selenium in mild disease. Tocilizumab, a drug used to suppress the immune system, has also been studied as
Graves'_ophthalmopathy
Inflammatory disease featuring pain and stiffness
rheumatica. Remitting seronegative symmetrical synovitis with pitting edema Tocilizumab "Polymyalgia Rheumatica". National Institute of Arthritis and Musculoskeletal
Polymyalgia_rheumatica
Private university in Philadelphia, US
February 14, 2026. "FDA approves tisagenlecleucel for B-cell ALL and tocilizumab for cytokine release syndrome". U.S. Food and Drug Administration. August
University_of_Pennsylvania
Contagious disease caused by SARS-CoV-2
randomised, controlled evidence that tocilizumab is an efficacious treatment for CRS. Prophylactic tocilizumab has been shown to increase serum IL-6
COVID-19
Pharmaceutical drug
inhibitors canakinumab (Ilaris) and rilonacept (Arcalyst), and IL-6 inhibitor tocilizumab (Actemra), anakinra can be considered as a treatment for refractory pericarditis
Anakinra
Chain reaction of white blood cell activation
negating the effect of drugs intended to activate the immune system. Tocilizumab, an anti-IL-6 monoclonal antibody, was FDA approved for steroid-refractory
Cytokine_release_syndrome
Drug repurposing research related to COVID-19
prostate cancer. Tocilizumab was jointly developed by Osaka University and Chugai, and was licensed in 2003 by Hoffmann-La Roche. Tocilizumab was approved
COVID-19 drug repurposing research
COVID-19_drug_repurposing_research
Human monoclonal antibody medication
symptoms. On 7 January 2021, following results from the REMAP-CAP trial, Tocilizumab and Sarilumab were added to the UK recommended list for COVID-19 treatment
Sarilumab
Medical condition
assessment. Clinical trials have shown that anti-interleukin-6 drugs, such as tocilizumab, and anti-interleukin-1 medications, such as anakinra, canakinumab, or
Systemic-onset juvenile idiopathic arthritis
Systemic-onset_juvenile_idiopathic_arthritis
Frequently fatal immune reaction
Philippe; CORIMUNO-19 Collaborative Group (20 October 2020). "Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe
Cytokine_storm
Group of autoimmune diseases resulting in abnormal growth of connective tissue
with cyclophosphamide, azathioprine with or without corticosteroids, tocilizumab, and nintedanib Pulmonary arterial hypertension with endothelin receptor
Scleroderma
Medical condition
which blocks both IL-1A and IL-1β. The monoclonal anti-IL6 antibody tocilizumab is another treatment option as effective as anakinra. The condition "juvenile-onset
Adult-onset_Still's_disease
Type of autoimmune arthritis
auranofin. Additionally, rituximab and tocilizumab are monoclonal antibodies and are also DMARDs. Use of tocilizumab is associated with a risk of increased
Rheumatoid_arthritis
Medical condition
[citation needed] Promising results are achieved with mycophenolate and tocilizumab. If treatment is not kept to a high standard, long-term damage or death
Takayasu's_arteritis
Chemical compound
today due to availability of TNF inhibitors and other agents, such as tocilizumab and tofacitinib. Penicillamine works by reducing numbers of T-lymphocytes
Penicillamine
Health system in the Seattle area
COVID-19 during the pandemic. The hospital is performing clinical trials of Tocilizumab to counter the effects of a cytokine storm, an extreme immune reaction
Swedish_Health_Services
Drug used to treat allergic diseases
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Dupilumab
Metabolic disease involving abnormal deposited amyloid proteins
anakinra, canakinumab, rilonacept) and interleukin-6 inhibitors (e.g., tocilizumab) may be considered. Management of ATTR amyloidosis will depend on its
Amyloidosis
Genetically engineered T cell
such as corticosteroids, and with tocilizumab, an anti-IL-6 monoclonal antibody. Early intervention using tocilizumab was shown to reduce the frequency
CAR_T_cell
Monoclonal antibody
Siplizumab Spartalizumab† Talizumab Teclistamab Teplizumab Tislelizumab Tocilizumab Toralizumab Tregalizumab Vatelizumab Vedolizumab Visilizumab Vobarilizumab
Theralizumab
Variant of a biopharmaceutical
Somatropin Genotropin Omnitrope Teriparatide Forsteo Movymia, Terrosa Tocilizumab RoActemra Tyenne Trastuzumab Herceptin Herzuma, Kanjinti, Ogivri, Ontruzant
Biosimilar
Rare genetic disease
therapy. However, anti-IL-1-resistant disease may also occur. Example. tocilizumab (a humanized monoclonal antibody against the interleukin-6 (IL-6) receptor)
Mevalonate_kinase_deficiency
(INN) tocamphyl (INN) toceranib (USAN, INN) tocilizumab (INN) tocilizumab-aazg tocilizumab-anoh tocilizumab-bavi tocofenoxate (INN) tocofersolan (INN)
List_of_drugs:_Tj–Tq
Excessive enlargement of the human aorta
Aortic valve repair Aortic dissection Cardarelli's sign Oliver's sign Tocilizumab Johnston KW, Rutherford RB, Tilson MD, Shah DM, Hollier L, Stanley JC
Aortic_aneurysm
American biotechnology corporation
product on June 30, 2006, the day the product was approved. 2010: Actemra (tocilizumab): The first interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody
Genentech
Group of lymphoproliferative disorders
First line treatment for iMCD is anti-IL-6 therapy with siltuximab (or tocilizumab, if siltuximab is not available). Siltuximab is the only FDA-approved
Castleman_disease
Medical condition
A ketogenic diet may help in some cases. The medications anakinra or tocilizumab have been tried. The risk of death, despite treatment is about 12%. The
Febrile infection-related epilepsy syndrome
Febrile_infection-related_epilepsy_syndrome
Diseases of the space or tissue between the alveoli of the lungs
and increased mean survival in people with ILD. The immunomodulator tocilizumab has a benefit in scleroderma associated ILD by helping to preserve lung
Interstitial_lung_disease
16 December 2022. "FDA approves tisagenlecleucel for B-cell ALL and tocilizumab for cytokine release syndrome". U.S. Food and Drug Administration (FDA)
List_of_gene_therapies
Protein-coding gene in the species Homo sapiens
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
EBI3
Preventative and therapeutic medications for COVID-19 infection
Archived from the original on 8 October 2020. Retrieved 6 April 2020. "Tocilizumab". Drugs.com. 7 June 2019. Archived from the original on 8 September 2020
COVID-19_drug_development
Monoclonal antibody
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Lebrikizumab
Protein-coding gene in the species Homo sapiens
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
IL1RAP
British epidemiologist and professor (born c. 1968)
life-saving COVID-19 drug, Dexamethasone. The trial also showed that Tocilizumab further reduces the risk of death for the sickest patients with COVID-19
Martin_Landray
Inflammation of the stomach lining
used for COVID-19 treatment have also been found to cause gastritis; tocilizumab and sarilumab are associated with chronic gastritis, while lopinavir/ritonavir
Gastritis
Protein found in humans
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Alpha-taxilin
Immune response against an organism's own healthy cells
etanercept), the B cell depleting agent rituximab, the anti-IL-6 receptor tocilizumab and the costimulation blocker abatacept have been shown to be useful
Autoimmunity
Mitigation of symptoms against the SARS-CoV-2-related disease
casirivimab/imdevimab. As of July 2021, outpatient drugs budesonide and tocilizumab showed promising results in some patients but remained under investigation
Treatment and management of COVID-19
Treatment_and_management_of_COVID-19
Medical condition
and blockade of the IL-6 pathway using the medications siltuximab and tocilizumab effectively treats some patients with iMCD. However, many patients with
Idiopathic multicentric Castleman disease
Idiopathic_multicentric_Castleman_disease
Protein that in humans is encoded by the IL33 gene
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin_33
Disease typically found in young children
SARS-CoV-2 and reports suggest intravenous immunoglobulin, anticoagulation, tocilizumab, plasmapheresis and steroids are potential treatments. Debate has occurred
Kawasaki_disease
Italian oncologist, researcher and winemaker
Ascierto researched alongside his colleagues the use of the arthritis drug tocilizumab to treat severe COVID-19 pneumonia, seeing some results. The results
Paolo_Antonio_Ascierto
Polish pianist
Piekarska, Anna; Polańska, Joanna; Flisiak, Robert (2021). "Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective
Aleksandra_Mikulska
Protein found in humans
and ciliary neurotrophic factor. Cluster of differentiation Anti-IL-6 Tocilizumab, a monoclonal antibody against IL6R Sarilumab, a monoclonal antibody
Interleukin-6_receptor
Biopharmaceutical drug
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Ustekinumab
Monoclonal antibody against IL-17
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Secukinumab
Mayor of Manila (born 1974)
to procure anti-COVID-19 medicines such as Molnupiravir, Remdesivir, Tocilizumab, Baricitinib, and Bexovid for aged 12 and above, all of which prevents
Isko_Moreno
Disease of children; pediatric comorbidity from COVID-19
have been used as a supplemental therapy to inhibit production of IL-6 (tocilizumab) or IL-1 (anakinra); TNF-α-inhibitors (infliximab) have also been used
Multisystem inflammatory syndrome in children
Multisystem_inflammatory_syndrome_in_children
Chemical compound
psoriatic arthritis; however, the antibody lacked a dose-response effect. Tocilizumab (Actemra) an anti-IL-6 receptor mAb Anti-IL-6, other anti-interleukin-6
Clazakizumab
British medical research charity
Leqembi (lecanemab) (Easai / BioArctic): for Alzheimer’s disease, Actemra (tocilizumab) (Hoffmann-La Roche/Chugai): for rheumatoid arthritis and other conditions
LifeArc
Antibody against interleukin 6
targeted IL-6 inhibition distinguishes it from IL-6 receptor blockers like tocilizumab, potentially offering a different safety profile with fewer immunosuppressive
Ziltivekimab
Medication used to treat autoimmune diseases
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Ixekizumab
American physician and government administrator (born 1972)
(February 9, 2019). "FDA approves tisagenlecleucel for B-cell ALL and tocilizumab for cytokine release syndrome". FDA. Archived from the original on September
Scott_Gottlieb
Mammalian protein found in Mus musculus
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin_4
Heterodimeric cytokine acting as mediator of inflammation
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin_23
Mammalian protein found in humans
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin_8
Medical condition
Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab". BMC Neurology. 14: 247. doi:10.1186/s12883-014-0247-3. PMC 4301061
Anti-AQP4_disease
Medical condition
investigation of TTM, use of immunosuppressive drugs such as steroids and tocilizumab, the use of cytoprotective perfusates, and the use cerebral tissue oxygen
Post-cardiac_arrest_syndrome
Type of coronavirus detected in 2021
Corticosteroids such as dexamethasone and IL6 receptor blockers such as tocilizumab (Actemra) were known to be effective for managing patients with the earlier
SARS-CoV-2_Omicron_variant
Overview of and topical guide to immunology
Olokizumab Sarilumab Satralizumab Secukinumab Siltuximab Sirukumab Spesolimab Tocilizumab Interleukin 5 Mepolizumab Immunoglobulin E Omalizumab Interferon Faralimomab
Outline_of_immunology
Group of proteins
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin_17
Rejection of transplanted tissue by the recipient's immune system
antibodies Basiliximab Daclizumab Monoclonal anti-IL-6R receptor antibodies Tocilizumab Polyclonal anti-T-cell antibodies Anti-thymocyte globulin (ATG) Anti-lymphocyte
Transplant_rejection
Acute inflammation diseases of the optic nerve and spinal cord
disease Idiopathic inflammatory demyelinating diseases Multiple sclerosis Tocilizumab Jarius, Sven; Paul, Friedemann; Weinshenker, Brian G.; Levy, Michael;
Neuromyelitis optica spectrum disorder
Neuromyelitis_optica_spectrum_disorder
American pediatric oncologist
Grupp injected her with a medication used to block the IL-6 receptor (tocilizumab) to treat this post-infusion illness (Cytokine release syndrome) which
Stephan_Grupp
Type of encephalitis
immunoglobulin.Other options include the use of rituximab (second-line) and tocilizumab or cyclophosphamide (next-line). A study in a South Korean hospital with
Autoimmune_encephalitis
Cell surface receptor for interleukin-10
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin-10_receptor
Monoclonal antibody
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Tildrakizumab
Mammalian protein found in humans
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin_21
Mammalian protein found in humans
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin_2
Protein involved in immune suppression
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin_35
Medical condition
treatment for Farber disease. Anti-inflammatory medications, specifically tocilizumab (an interleukin-6 receptor inhibitor), has been shown to improve inflammation
Farber_disease
Mammalian protein found in Homo sapiens
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin_23_subunit_alpha
Protein-coding gene in the species Homo sapiens
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
IL12A
Medical condition
least 2 years of maintenance therapy. Immunosuppressants Rituximab or tocilizumab may be used for refractory disease. 75% of people have a favorable response
Cerebral_vasculitis
Protein in the species Homo sapiens
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin_31
Cancer originating in lymph nodes
follicular lymphoma Large-cell lymphoma List of hematologic conditions Tocilizumab Xerri L, Dirnhofer S, Quintanilla-Martinez L, Sander B, Chan JK, Campo
Follicular_lymphoma
Atypical multiple sclerosis lesions
Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab". BMC Neurol. 14 (1): 247. doi:10.1186/s12883-014-0247-3. PMC 4301061
Tumefactive multiple sclerosis
Tumefactive_multiple_sclerosis
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
IL17RD
Monoclonal antibody medication
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Mepolizumab
Protein and coding gene in humans
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin-1 receptor antagonist
Interleukin-1_receptor_antagonist
Pharmaceutical drug
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Denileukin_diftitox
Monoclonal antibody
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Guselkumab
Monoclonal antibody
Siplizumab Spartalizumab† Talizumab Teclistamab Teplizumab Tislelizumab Tocilizumab Toralizumab Tregalizumab Vatelizumab Vedolizumab Visilizumab Vobarilizumab
Spartalizumab
Group of cytokines
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin_36
Family of interleukins
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
IL-10_family
Mammalian protein found in Homo sapiens
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interleukin_1_beta
Monoclonal antibody
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Briakinumab
Monoclonal antibody
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Gevokizumab
Disease-specific patient-reported outcome measure
Antony; Bernasconi, Corrado; Huizinga, TWJ (2013). "Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week
The Rheumatoid Arthritis Quality of Life Questionnaire
The_Rheumatoid_Arthritis_Quality_of_Life_Questionnaire
Species of legume
such as Infliximab (anti-TNF-α Ab), Anakinra (IL-1R antagonist) and Tocilizumab (anti-IL-6R Ab). In this study, the severity of rheumatoid arthritis
Glycine_tabacina
Marker on immune cells
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
CD4
Protein-coding gene in humans
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
IL22RA1
Protein found in humans
Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin 7 IL-8 See CXCR1 (IL-8Rα) and CXCR2
Interferon_lambda_receptor_1
travel, tourism, insurance
TOCILIZUMAB
TOCILIZUMAB
TOCILIZUMAB
TOCILIZUMAB
TOCILIZUMAB
TOCILIZUMAB
TOCILIZUMAB
TOCILIZUMAB
TOCILIZUMAB
travel, tourism, insurance